{"id":"ivabradine-procoralan","safety":{"commonSideEffects":[{"rate":null,"effect":"Bradycardia"},{"rate":"3-5","effect":"Phosphenes (visual symptoms)"},{"rate":null,"effect":"Atrial fibrillation"},{"rate":null,"effect":"Luminopsia"}]},"_chembl":{"chemblId":"CHEMBL4303271","moleculeType":"Small molecule","molecularWeight":"468.59"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ivabradine acts as a selective inhibitor of the hyperpolarization-activated cyclic nucleotide-gated (HCN) channel, specifically blocking the funny current that regulates the spontaneous diastolic depolarization in pacemaker cells. This mechanism reduces heart rate in a use-dependent manner, making it particularly useful in patients with elevated resting heart rate. Unlike beta-blockers, it does not affect atrioventricular conduction or myocardial contractility.","oneSentence":"Ivabradine selectively inhibits the funny current (If) in the sinoatrial node, reducing heart rate without affecting blood pressure or cardiac contractility.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:50:36.799Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic heart failure with reduced ejection fraction and elevated heart rate"},{"name":"Stable angina pectoris"}]},"trialDetails":[{"nctId":"NCT04031573","phase":"PHASE3","title":"Ivabradine for Heart Rate Control In Septic Shock","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-02-26","conditions":"Septic Shock","enrollment":429},{"nctId":"NCT05081999","phase":"PHASE4","title":"De-Adoption of Beta-Blockers in Patients With Stable Ischemic Heart Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alberta","startDate":"2023-01-30","conditions":"Stable Ischemic Heart Disease, Coronary Artery Disease, Beta-blocker Therapy","enrollment":59},{"nctId":"NCT06305780","phase":"PHASE2","title":"RECOVER-AUTONOMIC Platform Protocol","status":"COMPLETED","sponsor":"Kanecia Obie Zimmerman","startDate":"2024-03-11","conditions":"Long COVID, Long Covid19, Long Covid-19","enrollment":381},{"nctId":"NCT06305806","phase":"PHASE2","title":"RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)","status":"COMPLETED","sponsor":"Kanecia Obie Zimmerman","startDate":"2024-03-11","conditions":"Long COVID, Long Covid19, Long Covid-19","enrollment":181},{"nctId":"NCT02584439","phase":"PHASE3","title":"Effect of Pharmacological Heart Rate Reduction on Visco-elastic Properties of the Arterial Wall (BRADYVASC)","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2015-12-03","conditions":"Healthy, Vascular Stiffness, Aging","enrollment":20},{"nctId":"NCT04853797","phase":"NA","title":"Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migraine Without Aura (ILIM)","status":"COMPLETED","sponsor":"Danish Headache Center","startDate":"2021-05-11","conditions":"Headache, Migraine Without Aura","enrollment":37},{"nctId":"NCT07268170","phase":"PHASE2, PHASE3","title":"Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Gødstrup Hospital","startDate":"2025-12-15","conditions":"Coronary Arterial Disease (CAD), Ischemic Heart Disease (IHD)","enrollment":350},{"nctId":"NCT05279651","phase":"PHASE3","title":"Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jagiellonian University","startDate":"2022-06-13","conditions":"Myocardial Injury After Noncardiac Surgery (MINS), Myocardial Ischemia","enrollment":2146},{"nctId":"NCT07135258","phase":"PHASE4","title":"Atrial Fibrillation: In Search for the Optimal Target for Rate Control","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-10-01","conditions":"Atrial Fibrillation (Permanent), Atrial Fibrillation (AF)","enrollment":200},{"nctId":"NCT05636774","phase":"NA","title":"Empower the Heart of Patients With Terminal Cancer Using Cardiac Medicines Trial","status":"COMPLETED","sponsor":"University Hospital, Essen","startDate":"2022-12-12","conditions":"Patients With Advanced Cancer Receiving Specialized Palliative Care","enrollment":97},{"nctId":"NCT03168529","phase":"PHASE4","title":"Trial Assessing the Effectiveness of Ivabradine Started at Discharge From the Observation Unit","status":"TERMINATED","sponsor":"Phillip Levy","startDate":"2018-07-01","conditions":"Heart Failure","enrollment":19},{"nctId":"NCT05572957","phase":"NA","title":"LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2022-10-14","conditions":"Non-ischemic Cardiomyopathy, Heart Failure, Left Bundle-Branch Block","enrollment":50},{"nctId":"NCT06742164","phase":"NA","title":"Role of Ivabradine for Heart Rate Control in Management of Patients With Sepsis and Septic Shock","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2024-12-30","conditions":"Heart Rhythm Disorder","enrollment":76},{"nctId":"NCT03631654","phase":"PHASE4","title":"Ivabradine in Stage D Heart Failure Patients on Chronic Inotropes","status":"WITHDRAWN","sponsor":"University of Maryland, Baltimore","startDate":"2020-10-01","conditions":"Heart Failure NYHA Class IV","enrollment":""},{"nctId":"NCT06670690","phase":"NA","title":"Comparison Between Atenolol,Propnalol and Ivabradine","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2023-09-01","conditions":"Intraoperative Bleeding","enrollment":120},{"nctId":"NCT04285736","phase":"PHASE2, PHASE3","title":"Efficacy of Oral Ivabradine in Patients Presenting With NSTEMI","status":"COMPLETED","sponsor":"Cairo University","startDate":"2014-12","conditions":"NSTEMI","enrollment":100},{"nctId":"NCT02446990","phase":"PHASE3","title":"Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure","status":"COMPLETED","sponsor":"Institut de Recherches Internationales Servier","startDate":"2009-09","conditions":"Coronary Artery Disease","enrollment":19102},{"nctId":"NCT00202579","phase":"PHASE2","title":"Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure","status":"COMPLETED","sponsor":"Institut de Recherches Internationales Servier","startDate":"2004-09","conditions":"Heart Failure, Congestive","enrollment":12},{"nctId":"NCT06505668","phase":"NA","title":"Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial.","status":"RECRUITING","sponsor":"All India Institute of Medical Sciences, Bhubaneswar","startDate":"2023-08-01","conditions":"Treatment Resistant Schizophrenia, Clozapine Adverse Reaction, Heart Rate Variability","enrollment":40},{"nctId":"NCT04186286","phase":"PHASE2","title":"Crossover Study of Propranolol vs Ivabradine in POTS","status":"RECRUITING","sponsor":"University of Calgary","startDate":"2021-02-01","conditions":"Postural Tachycardia Syndrome","enrollment":20},{"nctId":"NCT04881318","phase":"NA","title":"Compression Garments in the Community With POTS","status":"RECRUITING","sponsor":"University of Calgary","startDate":"2021-05-17","conditions":"Postural Orthostatic Tachycardia Syndrome","enrollment":30},{"nctId":"NCT06371222","phase":"PHASE4","title":"Role of Ivabradine on Heart Rate and Quality of Life in Patients With Mitral Stenosis in Sinus Rhythm","status":"COMPLETED","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2023-02-01","conditions":"Mitral Stenosis","enrollment":42},{"nctId":"NCT06312891","phase":"","title":"Value of Heart Rate Lowering Therapy in Acute Myocarditis","status":"RECRUITING","sponsor":"Assiut University","startDate":"2024-04-01","conditions":"Myocarditis","enrollment":150},{"nctId":"NCT04111133","phase":"NA","title":"Ivabradine in Cirrhotic Cardiomyopathy","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2020-01-01","conditions":"Cirrhotic Cardiomyopathy, Left Ventricular Dysfunction, Cirrhosis, Liver","enrollment":130},{"nctId":"NCT05882708","phase":"PHASE4","title":"Effect of Heart Rate Control With Ivabradine on Hemodynamic in Patients With Sepsis","status":"UNKNOWN","sponsor":"Second Affiliated Hospital of Guangzhou Medical University","startDate":"2023-06-01","conditions":"Sepsis, Ivabradine, Hemodynamics","enrollment":172},{"nctId":"NCT02973594","phase":"PHASE4","title":"Pulse Reduction On Beta-blocker and Ivabradine Therapy","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2016-11","conditions":"Dilated Cardiomyopathies, Idiopathic, Heart Failure, Systolic, Ventricular Remodeling","enrollment":28},{"nctId":"NCT05481177","phase":"PHASE4","title":"Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort","status":"UNKNOWN","sponsor":"Uniformed Services University of the Health Sciences","startDate":"2023-06-14","conditions":"Long Haul COVID, Postural Orthostatic Tachycardia Syndrome","enrollment":250},{"nctId":"NCT05973591","phase":"","title":"The Impact of Ivabradine on Left Ventricular Reverse Remodeling in Nonischemic Dilated Cardiomyopathy (NIDCM) on Current Medical Therapy Era","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2023-07-15","conditions":"Dilated Cardiomyopathy, Ventricular Remodeling, Heart Failure, Reduced Ejection Fraction","enrollment":500},{"nctId":"NCT02592499","phase":"NA","title":"Swedish Evaluation of Left Ventricular Assist Device as Permanent Treatment in End-stage Heart Failure","status":"UNKNOWN","sponsor":"Vastra Gotaland Region","startDate":"2016-06","conditions":"End-stage Heart Failure","enrollment":80},{"nctId":"NCT05580510","phase":"PHASE2, PHASE3","title":"\" Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD \"","status":"UNKNOWN","sponsor":"Instituto Nacional de Cardiologia Ignacio Chavez","startDate":"2023-02-06","conditions":"Congenital Heart Disease, Heart Failure, Heart Failure With Reduced Ejection Fraction","enrollment":160},{"nctId":"NCT05594342","phase":"PHASE3","title":"Ivabradine Effects in Cardiogenic Shock Requiring Inotropic Support","status":"UNKNOWN","sponsor":"The Young Investigator Group of Cardiovascular Research","startDate":"2022-07-01","conditions":"Heart Failure, Cardiogenic Shock, Ischemic Heart Disease","enrollment":200},{"nctId":"NCT03718273","phase":"PHASE3","title":"IvaBRAdine blocK of Funny Current for Heart Rate Control in permanEnt Atrial Fibrillation. (BRAKE-AF Study).","status":"COMPLETED","sponsor":"Adolfo Fontenla","startDate":"2018-10-19","conditions":"Atrial Fibrillation, Heart Diseases","enrollment":68},{"nctId":"NCT05141071","phase":"PHASE2","title":"Effect of Ivabradine on Microcirculation and Cardiac Output in Septic Shock Patients","status":"COMPLETED","sponsor":"Cairo University","startDate":"2021-11-25","conditions":"Septic Shock","enrollment":44},{"nctId":"NCT05261464","phase":"PHASE4","title":"Heart Rate Controller in Computed Tomography Coronary Angiography","status":"UNKNOWN","sponsor":"Mahidol University","startDate":"2021-01-30","conditions":"Heart Rate, Coronary Computed Tomography Angiography","enrollment":246},{"nctId":"NCT05348057","phase":"PHASE4","title":"Clinical Study of CMR to Evaluate the Effect of Ivabradine on the Improvement of Left Ventricular Remodeling in STEMI Patients After Primary PCI","status":"UNKNOWN","sponsor":"Qian geng","startDate":"2021-08-01","conditions":"Cardiovascular Diseases","enrollment":240},{"nctId":"NCT04436016","phase":"PHASE4","title":"PeRiOperaTivE CardioproTection With Ivabradine in Non-cardiac Surgery","status":"COMPLETED","sponsor":"University Hospital, Geneva","startDate":"2020-10-05","conditions":"Myocardial Injury, Myocardial Ischemia","enrollment":78},{"nctId":"NCT03137537","phase":"PHASE2","title":"Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.","status":"TERMINATED","sponsor":"Dana-Farber Cancer Institute","startDate":"2018-02-27","conditions":"Lymphoma, Autonomic Imbalance, Cancer Survivorship","enrollment":23},{"nctId":"NCT04217135","phase":"PHASE4","title":"The Prognostic Impact of Using High-dose Hydralazine in Severe Systolic Heart Failure With Hemodynamically Significant Mitral Regurgitation","status":"UNKNOWN","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2017-01-01","conditions":"Systolic Heart Failure Stage D (Disorder), Mitral Regurgitation","enrollment":400},{"nctId":"NCT05168189","phase":"","title":"the Role of Ivabradine in Causing AF in Patients With Chronic Coronary Syndrome","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-08","conditions":"AF - Atrial Fibrillation","enrollment":180},{"nctId":"NCT03456856","phase":"PHASE4","title":"A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction.","status":"COMPLETED","sponsor":"Amgen","startDate":"2017-09-28","conditions":"Heart Failure (HF)","enrollment":30},{"nctId":"NCT04448899","phase":"PHASE4","title":"Ivabradine in Patients With Congestive Heart Failure","status":"COMPLETED","sponsor":"Damanhour University","startDate":"2020-06-01","conditions":"Congestive Heart Failure","enrollment":60},{"nctId":"NCT03987204","phase":"PHASE1","title":"Ivabradine for Rate Control in Permanent Atrial Fibrillation","status":"COMPLETED","sponsor":"Yale University","startDate":"2019-06-15","conditions":"Atrial Fibrillation, Atrial Fibrillation, Persistent","enrollment":4},{"nctId":"NCT03182725","phase":"PHASE3","title":"Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2018-02-06","conditions":"Postural Orthostatic Tachycardia Syndrome","enrollment":37},{"nctId":"NCT04549805","phase":"","title":"Troponin to Risk Stratify Patients for Computed Tomography Coronary Angiography","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2018-12-04","conditions":"Coronary Artery Disease, Acute Coronary Syndrome","enrollment":250},{"nctId":"NCT04405804","phase":"PHASE2","title":"Early Administration of Ivabradine in Children With Heart Failure","status":"UNKNOWN","sponsor":"Bambino Gesù Hospital and Research Institute","startDate":"2020-06-20","conditions":"Acute Heart Failure, Dilated Cardiomyopathy","enrollment":9},{"nctId":"NCT03105219","phase":"PHASE3","title":"IvaBradinE to Treat MicroalbumiNuria in Patients With Type 2 Diabetes and Coronary Heart Disease","status":"WITHDRAWN","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2017-07-01","conditions":"Diabetic Kidney Disease","enrollment":""},{"nctId":"NCT04580342","phase":"PHASE2","title":"Ivabradine Versus Propranolol for Induced Hypotension in Endoscopic Sinus Surgery","status":"UNKNOWN","sponsor":"Ahmed talaat ahmed aly","startDate":"2020-10-15","conditions":"Hypotension","enrollment":60},{"nctId":"NCT00825123","phase":"PHASE4","title":"Effects of Heart Rate Reduction on Central Arterial Pressure in Healthy Individuals","status":"TERMINATED","sponsor":"Bayside Health","startDate":"2008-10","conditions":"Central Arterial Pressure","enrollment":2},{"nctId":"NCT00815100","phase":"PHASE4","title":"Effects of the Ivabradine on Reduction of Inflammatory Markers in Patients With Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Hospital Universitario de Canarias","startDate":"2009-04","conditions":"Acute Coronary Syndromes","enrollment":27},{"nctId":"NCT04308031","phase":"PHASE3","title":"Efficacy of Ivabradine in Patient With Both Persistent Atrial Fibrillation and Heart Failure With Reduce Ejection Fraction","status":"UNKNOWN","sponsor":"Chun-Yao Huang","startDate":"2018-08-26","conditions":"Atrial Fibrillation, Ivabradine, Heart Failure","enrollment":100},{"nctId":"NCT01868880","phase":"PHASE4","title":"Effect of Ivabradine and Beta-blockers Combination Versus Beta-blockers Up-titration on Right Ventricular Pacing","status":"WITHDRAWN","sponsor":"Policlinico Casilino ASL RMB","startDate":"2016-02","conditions":"Heart Rate Control in ICD Patients With Heart Failure","enrollment":""},{"nctId":"NCT02441218","phase":"PHASE3","title":"Effects of Ivabradine on Cardiovascular Events in Patients With Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-year International Multicentre Study","status":"COMPLETED","sponsor":"Institut de Recherches Internationales Servier","startDate":"2006-09","conditions":"Chronic Heart Failure","enrollment":6505},{"nctId":"NCT02247245","phase":"NA","title":"The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients.","status":"COMPLETED","sponsor":"University of Leeds","startDate":"2014-09","conditions":"Chronic Heart Failure, Atrial Fibrillation, Arrhythmia, Sinus","enrollment":40},{"nctId":"NCT04208594","phase":"NA","title":"Efficacy of Ivabradine Versus Propranolol Premedication During Hypotensive Anesthesia in Endoscopic Sinus Surgery","status":"UNKNOWN","sponsor":"Alexandria University","startDate":"2019-12-11","conditions":"Ivabradine, Propranolol, Hypotensive Anesthesia","enrollment":50},{"nctId":"NCT04030546","phase":"PHASE3","title":"Ivabradine to Prevent Anthracycline-induced Cardiotoxicity","status":"UNKNOWN","sponsor":"Vilnius University","startDate":"2019-06-01","conditions":"Patients With Cancer","enrollment":128},{"nctId":"NCT02827500","phase":"PHASE4","title":"Predischarge Initiation of Ivabradine in the Management of Heart Failure (PRIME-HF)","status":"COMPLETED","sponsor":"Duke University","startDate":"2016-07","conditions":"Heart Failure","enrollment":104},{"nctId":"NCT03387605","phase":"PHASE4","title":"Effect of Ivabradine in Stage D HF/Cardiogenic Shock Patients on Dobutamine","status":"UNKNOWN","sponsor":"Loyola University","startDate":"2018-03-15","conditions":"Heart Failure, Cardiogenic Shock, Tachycardia","enrollment":40},{"nctId":"NCT03830957","phase":"NA","title":"Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker","status":"UNKNOWN","sponsor":"Rajaie Cardiovascular Medical and Research Center","startDate":"2018-11-26","conditions":"Heart Failure, CT Angiography, Ischemic Cardiomyopathy","enrollment":200},{"nctId":"NCT03650205","phase":"NA","title":"Ivabradine to Prevent Anthracycline-induced Cardiotoxicity","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"2019-01-22","conditions":"Neoplasms, Heart Failure, Cardiotoxicity","enrollment":160},{"nctId":"NCT03866395","phase":"PHASE4","title":"Effects of Ivabradine on Residual Myocardial Ischemia After PCI","status":"COMPLETED","sponsor":"Azienda Policlinico Umberto I","startDate":"2015-03-05","conditions":"Angina Pectoris, Stable","enrollment":28},{"nctId":"NCT03405831","phase":"PHASE4","title":"Effect of Ivabradine on Exercise Capacity After Heart Transplantation","status":"UNKNOWN","sponsor":"Finn Gustafsson","startDate":"2018-04-17","conditions":"Cardiac Allograft Vasculopathy, Transplanted Heart Complication","enrollment":35},{"nctId":"NCT03619187","phase":"PHASE3","title":"An Interventional Study to Evaluate the Effect of Ivabradine on Exercise Capacity in Heart Transplant Recipients","status":"WITHDRAWN","sponsor":"Amgen","startDate":"2018-11-02","conditions":"Heart Transplantation, Elevated Resting Heart Rate","enrollment":""},{"nctId":"NCT03710057","phase":"","title":"Effect of Ivabradine in Lowering Heart Rate and Quality of Life in Chronic Heart Failure Patients","status":"COMPLETED","sponsor":"Getz Pharma","startDate":"2016-12-01","conditions":"Chronic Heart Failure","enrollment":50},{"nctId":"NCT03701880","phase":"NA","title":"Early Use of Ivabradine in Heart Failure","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2018-09-16","conditions":"Heart Failure With Reduced Ejection Fraction, Decompensated Heart Failure","enrollment":50},{"nctId":"NCT02507050","phase":"PHASE4","title":"Ivabradine and Post-revascularisation Microcirculatory Dysfunction","status":"WITHDRAWN","sponsor":"Liverpool Heart and Chest Hospital NHS Foundation Trust","startDate":"2016-03","conditions":"Coronary Artery Disease, Angina","enrollment":""},{"nctId":"NCT03245996","phase":"PHASE4","title":"The Impact of Heart Rate on Central Blood Pressure in Sick Sinus Syndrome Patients With a Permanent Cardiac Pacemaker","status":"COMPLETED","sponsor":"Tartu University Hospital","startDate":"2015-06","conditions":"Aortic Blood Pressure","enrollment":27},{"nctId":"NCT00143507","phase":"PHASE3","title":"The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction","status":"COMPLETED","sponsor":"Institut de Recherches Internationales Servier","startDate":"2004-12","conditions":"Coronary Disease, Ventricular Dysfunction, Left","enrollment":10917},{"nctId":"NCT03485482","phase":"PHASE3","title":"Pharmacokinetic Drug-Drug Interaction Between Bisoprolol and Ivabradine in Healthy Volunteers","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2018-03-01","conditions":"Cardiovascular Diseases","enrollment":18},{"nctId":"NCT02764970","phase":"","title":"Heart Rate Reducing Therapy in Cardiac CT Using Ivabradine and Bisoprolol","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2015-02","conditions":"Bradycardia","enrollment":112},{"nctId":"NCT00202566","phase":"PHASE3","title":"Efficacy and Safety of Ivabradine on Top of Atenolol in Stable Angina Pectoris","status":"COMPLETED","sponsor":"Institut de Recherches Internationales Servier","startDate":"2005-06","conditions":"Angina Pectoris","enrollment":750},{"nctId":"NCT03437369","phase":"PHASE4","title":"Efficacy and Safety on Heart Rate Control With Ivabradine on Cardiogenic Shock","status":"UNKNOWN","sponsor":"Hospital Universitario Ramon y Cajal","startDate":"2018-05","conditions":"Cardiogenic Shock","enrollment":22},{"nctId":"NCT02294292","phase":"NA","title":"Therapeutic Approach to Diastolic Dysfunction in Chronic Liver Disease Patients and Its Impact on Morbidity and Mortality","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2014-07-01","conditions":"Diastolic Dysfunction, Chronic Liver Disease","enrollment":189},{"nctId":"NCT03367026","phase":"NA","title":"Reducing Elevated Heart Rate in Patients With Severe Sepsis by Ivabradine","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2018-01-01","conditions":"Sepsis, Severe","enrollment":70},{"nctId":"NCT01796093","phase":"","title":"Digoxin Versus Ivabradine in Heart Failure With Preserved Systolic Function","status":"COMPLETED","sponsor":"Cocco, Giuseppe, M.D.","startDate":"2008-04","conditions":"Heart Failure, Atrial Fibrillation","enrollment":42},{"nctId":"NCT02236247","phase":"PHASE1, PHASE2","title":"Control of Sinus Node Tachycardia as an Additional Therapy in Patients With Decompensated Heart Failure","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"2013-05","conditions":"Decompensated Heart Failure","enrollment":50},{"nctId":"NCT01657136","phase":"PHASE3","title":"Ivabradine Versus Beta-blockers in the Treatment of Inappropriate Sinus Tachycardia","status":"COMPLETED","sponsor":"Policlinico Casilino ASL RMB","startDate":"2013-09","conditions":"Inappropriate Sinus Tachycardia","enrollment":20},{"nctId":"NCT02086422","phase":"NA","title":"Iatrogenic Chronotropic Incompetence and Exercise Tolerance in Heart Failure","status":"UNKNOWN","sponsor":"The Leeds Teaching Hospitals NHS Trust","startDate":"2013-07","conditions":"Chronic Heart Failure","enrollment":""},{"nctId":"NCT02681978","phase":"PHASE4","title":"Ivabradine to Improve Endothelial Function in Patients With Coronary Artery Disease","status":"COMPLETED","sponsor":"Campus Bio-Medico University","startDate":"2014-02","conditions":"Coronary Artery Disease","enrollment":70},{"nctId":"NCT02008110","phase":"PHASE4","title":"Carbohydrate Antigen 125-guided Therapy in Heart Failure","status":"COMPLETED","sponsor":"Fundación para la Investigación del Hospital Clínico de Valencia","startDate":"2011-12","conditions":"Heart Failure","enrollment":360},{"nctId":"NCT02623569","phase":"PHASE2","title":"To Assess the Anti-anginal Safety and Efficacy of Ivabradine in Subjects With Stable，Symptomatic Chronic Angina","status":"UNKNOWN","sponsor":"Xintong Pharmacy Company","startDate":"2014-10","conditions":"Angina Pectoris","enrollment":336},{"nctId":"NCT02354573","phase":"NA","title":"The Role of Chronotropic Incompetence in Heart Failure With Normal Ejection Fraction (HFNEF)","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2011-12","conditions":"Heart Failure","enrollment":121},{"nctId":"NCT00757055","phase":"PHASE2","title":"If Channel Blockade With Ivabradine in Patients With Diastolic Heart Failure","status":"WITHDRAWN","sponsor":"St Vincent's University Hospital, Ireland","startDate":"2012-12","conditions":"Diastolic Heart Failure","enrollment":""},{"nctId":"NCT01755663","phase":"PHASE4","title":"Comparison of Efficacy of Ivabradine Versus Metoprolol","status":"UNKNOWN","sponsor":"Col. Suthee Panichkul","startDate":"2014-12","conditions":"Coronary Artery Disease","enrollment":60},{"nctId":"NCT01178528","phase":"PHASE3","title":"Heart Rate Reduction in Heart Failure","status":"COMPLETED","sponsor":"IRCCS San Raffaele","startDate":"2009-09","conditions":"Heart Failure","enrollment":121},{"nctId":"NCT02188082","phase":"PHASE2, PHASE3","title":"Clinical Trial of Systolic Heart Failure Treatment of IvabRadine Hemisulfate Sustained-release Tablets （FIRST）","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2014-05","conditions":"Chronic Systolic Heart Failure","enrollment":336},{"nctId":"NCT02166060","phase":"PHASE4","title":"Ivabradine in Patients With an Unsatisfactory Percentage of Cardiac Resynchronization Therapy","status":"UNKNOWN","sponsor":"Medical University of Warsaw","startDate":"2014-08","conditions":"Heart Failure","enrollment":60},{"nctId":"NCT02046044","phase":"PHASE4","title":"Digoxin Versus Ivabradine in Heart Failure With Reduced Ejection Fraction","status":"UNKNOWN","sponsor":"Kocaeli University","startDate":"2014-01","conditions":"Heart Failure","enrollment":60},{"nctId":"NCT01699776","phase":"PHASE4","title":"Efficacy Study of Digoxin & Ivabradine to Treat Heart Failure","status":"COMPLETED","sponsor":"Cocco, Giuseppe, M.D.","startDate":"2008-04","conditions":"Cardiac Failure","enrollment":22},{"nctId":"NCT01039389","phase":"NA","title":"Promotion of Coronary Collateral Function by Ivabradine-Induced Bradycardia in Patients With Coronary Artery Disease","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2009-10","conditions":"Coronary Artery Disease","enrollment":43},{"nctId":"NCT01804010","phase":"PHASE1","title":"Pharmacokinetic, Pharmacodynamic Profiles and Safety After Oral Administration of Ivabradine in Male Healthy Korean Volunteers","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2007-05","conditions":"Healthy Individual","enrollment":48},{"nctId":"NCT01768585","phase":"PHASE4","title":"Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease","status":"UNKNOWN","sponsor":"University Hospital, Saarland","startDate":"2012-12","conditions":"Coronary Artery Disease, Coronary Arteriosclerosis","enrollment":50},{"nctId":"NCT01761825","phase":"PHASE2","title":"The Effect of Ivabradine on Patients With Postural Tachycardia Syndrome","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2012-12","conditions":"Postural Tachycardia Syndrome","enrollment":20},{"nctId":"NCT01425164","phase":"PHASE4","title":"Ischemia In Hemodialysed Patients: Ivabradine Versus Carvedilol","status":"UNKNOWN","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2011-01","conditions":"Coronary Heart Disease, Angina, Hemodialysis","enrollment":220},{"nctId":"NCT01364077","phase":"PHASE4","title":"Ivabradine in Hemodialysed Patients With Increased Heart Rate","status":"UNKNOWN","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2010-01","conditions":"High Heart Rate","enrollment":100},{"nctId":"NCT01365286","phase":"PHASE4","title":"HR-lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease","status":"COMPLETED","sponsor":"Medical University of Lodz","startDate":"2009-05","conditions":"Asthma, Chronic Obstructive Pulmonary Disease (COPD)","enrollment":40},{"nctId":"NCT01373619","phase":"PHASE4","title":"Heart Failure With Normal Ejection Fraction (HFNEF) in Hemodialysed Patients: Beneficial Effect of Ivabradine","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2010-01","conditions":"Heart Failure","enrollment":150},{"nctId":"NCT01029223","phase":"PHASE4","title":"The Influence of Heart Rate Reduction Upon Central Arterial Pressure in Younger and Older Healthy Individuals","status":"WITHDRAWN","sponsor":"Bayside Health","startDate":"2008-10","conditions":"Blood Pressure","enrollment":42},{"nctId":"NCT01022463","phase":"PHASE3","title":"Effect of Ivabradine on Heart Rate & Effort Tolerance in Mitral Stenosis in Sinus Rhythm","status":"COMPLETED","sponsor":"Govind Ballabh Pant Hospital","startDate":"2009-11","conditions":"Mitral Stenosis","enrollment":50},{"nctId":"NCT01186783","phase":"PHASE2","title":"Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by Ivabradine","status":"UNKNOWN","sponsor":"Martin-Luther-Universität Halle-Wittenberg","startDate":"2010-05","conditions":"Multiple Organ Dysfunction Syndrome","enrollment":70},{"nctId":"NCT00865917","phase":"PHASE2","title":"Cardiovascular Effects of Selective I(f)-Channel Blockade","status":"UNKNOWN","sponsor":"Hannover Medical School","startDate":"2008-11","conditions":"Postural Orthostatic Tachycardia Syndrome","enrollment":40}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"AORTIC ARTERIOSCLEROSIS"},{"count":1,"reaction":"ATRIOVENTRICULAR BLOCK COMPLETE"},{"count":1,"reaction":"CHEST PAIN"},{"count":1,"reaction":"DYSPNOEA"},{"count":1,"reaction":"FATIGUE"},{"count":1,"reaction":"HYPERKALAEMIA"},{"count":1,"reaction":"RENAL FAILURE"}],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Ivabradine (Procoralan)","genericName":"Ivabradine (Procoralan)","companyName":"Medical University of Lodz","companyId":"medical-university-of-lodz","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ivabradine selectively inhibits the If (funny) current in the sinoatrial node, reducing heart rate without affecting blood pressure or cardiac contractility. Used for Chronic heart failure with reduced ejection fraction (HFrEF) in patients with elevated heart rate, Angina pectoris in patients unable to tolerate or contraindicated for beta-blockers.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}